Traders Sell Maxim Integrated (MXIM) on Strength (MXIM)

Traders sold shares of Maxim Integrated (NASDAQ:MXIM) on strength during trading on Friday. $21.29 million flowed into the stock on the tick-up and $203.34 million flowed out of the stock on the tick-down, for a money net flow of $182.05 million out of the stock. Of all equities tracked, Maxim Integrated had the 0th highest net out-flow for the day. Maxim Integrated traded up $0.35 for the day and closed at $59.18

Several equities research analysts recently commented on MXIM shares. Macquarie cut Maxim Integrated from an “outperform” rating to a “neutral” rating and raised their target price for the stock from $62.00 to $64.00 in a research note on Wednesday, February 28th. Citigroup reduced their price objective on Maxim Integrated from $59.00 to $56.00 and set a “neutral” rating for the company in a research note on Monday, April 30th. BidaskClub cut Maxim Integrated from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 21st. Zacks Investment Research raised Maxim Integrated from a “sell” rating to a “hold” rating in a research note on Monday, January 29th. Finally, ValuEngine cut Maxim Integrated from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Twelve research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $57.38.

Get Maxim Integrated alerts:

The company has a quick ratio of 3.82, a current ratio of 4.16 and a debt-to-equity ratio of 0.51. The firm has a market cap of $16.55 billion, a price-to-earnings ratio of 27.92, a P/E/G ratio of 2.15 and a beta of 1.16.

Maxim Integrated (NASDAQ:MXIM) last posted its earnings results on Thursday, April 26th. The semiconductor company reported $0.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.03. Maxim Integrated had a return on equity of 35.78% and a net margin of 17.82%. The company had revenue of $648.60 million for the quarter, compared to analyst estimates of $640.50 million. During the same quarter last year, the company earned $0.56 earnings per share. The company’s revenue for the quarter was up 11.6% on a year-over-year basis. equities analysts forecast that Maxim Integrated will post 2.68 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 14th. Stockholders of record on Thursday, May 31st will be issued a $0.42 dividend. The ex-dividend date is Wednesday, May 30th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.84%. Maxim Integrated’s dividend payout ratio is presently 79.25%.

In other news, VP David Loftus sold 9,084 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $61.42, for a total value of $557,939.28. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Tunc Doluca sold 31,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $60.76, for a total value of $1,883,560.00. The disclosure for this sale can be found here. Insiders sold 98,580 shares of company stock worth $5,803,934 in the last 90 days. Corporate insiders own 1.11% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Schwab Charles Investment Management Inc. lifted its holdings in Maxim Integrated by 0.7% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,230,789 shares of the semiconductor company’s stock worth $64,346,000 after acquiring an additional 8,447 shares during the period. James Investment Research Inc. bought a new stake in Maxim Integrated during the fourth quarter worth $1,615,000. Cerebellum GP LLC bought a new stake in Maxim Integrated during the fourth quarter worth $121,000. Robeco Institutional Asset Management B.V. lifted its holdings in Maxim Integrated by 49.3% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 444,297 shares of the semiconductor company’s stock worth $23,229,000 after acquiring an additional 146,688 shares during the period. Finally, Eqis Capital Management Inc. lifted its holdings in Maxim Integrated by 10.2% during the fourth quarter. Eqis Capital Management Inc. now owns 34,457 shares of the semiconductor company’s stock worth $1,801,000 after acquiring an additional 3,199 shares during the period. Institutional investors own 90.28% of the company’s stock.

About Maxim Integrated

Maxim Integrated Products, Inc designs, develops, manufactures, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally. The company also provides a range of high-frequency process technologies and capabilities for use in custom designs.

Top China Stocks To Buy Right Now

tags:RIGL,WERN,MDC,SHBI,
Jaydeb Dey

Stewart & Mackertich Wealth Management Ltd

The Nifty yesterday ended 1.14 percent down at 10,128.40. Early morning positive opening got sold off, amid US-China trade worries, towards ending the session below critical supports placed around 10,210 and 10,170. Nifty ending the session with a big bearish candle soon after yesterday��s Falling-Wedge pattern breakout is disappointing for the bulls.

However, Falling- Wedge pattern breakout and the critical support placed around 10,080 are well intact and may arrest severe down fall here on. Next support is placed around 10,050. Also, RBI��s bi-monthly monetary policy scheduled to be released today is awaited.

On the Nifty hourly chart; midsession violent sell off led the Index closing below the neck line, placed around 10,210, of the Inverse ��Head-and-Shoulder�� pattern discussed in our previous communication. Hence, it may remain under pressure in today's session. However, that��s not an enough proof to invalidate the bullish reversal pattern as of now. Pivotal support is placed around 10,080. Pull back may face resistance on rise around 10,180 and 10,210.

Top China Stocks To Buy Right Now: Rigel Pharmaceuticals Inc.(RIGL)

Advisors' Opinion:

• [By Dan Caplinger]

  Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven't seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here's why they did so well.

Top China Stocks To Buy Right Now: Werner Enterprises, Inc.(WERN)

Advisors' Opinion:

• [By ]

  Werner Enterprises (Nasdaq: WERN) competes in the full-truckload (FTL) segment of the industry where drivers deliver entire truck-loads between two points, rather than making many stops to consolidate partial loads as in the LTL segment. This could mean that the company has relatively more to gain from autonomous trucking since highway driving is a larger portion of total drive time.

• [By Max Byerly]

  Werner Enterprises (NASDAQ: WERN) and Universal Logistics (NASDAQ:ULH) are both transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Top China Stocks To Buy Right Now: M.D.C. Holdings, Inc.(MDC)

Advisors' Opinion:

• [By Stephan Byrd]

  MDC (NYSE:MDC)‘s stock had its “buy” rating reiterated by equities research analysts at Raymond James in a report released on Tuesday, MarketBeat reports. They presently have a $39.00 target price on the construction company’s stock, up from their previous target price of $35.00. Raymond James’ target price indicates a potential upside of 26.09% from the company’s current price.

• [By Tyler Crowe]

  Buying a new home isn't something you go out and do every day. So, as you can imagine, sales at homebuilders can be quite seasonal and a bit lumpy at times. One quarter of weak sales numbers isn't that big of a deal, really. However, this was the second quarter in a row where M.D.C. Holdings (NYSE:MDC) didn't look that great, especially when you consider the backdrop of an incredibly robust housing market and other homebuilders posting double-digit growth rates.

Top China Stocks To Buy Right Now: Shore Bancshares Inc(SHBI)

Advisors' Opinion:

• [By Joseph Griffin]

  Media coverage about Shore Bancshares (NASDAQ:SHBI) has trended somewhat positive on Sunday, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Shore Bancshares earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 47.376414932679 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

• [By Joseph Griffin]

  LSV Asset Management increased its stake in Shore Bancshares Inc (NASDAQ:SHBI) by 134.4% during the 1st quarter, Holdings Channel reports. The firm owned 157,489 shares of the bank’s stock after acquiring an additional 90,289 shares during the period. LSV Asset Management’s holdings in Shore Bancshares were worth $2,970,000 as of its most recent filing with the Securities and Exchange Commission.

Buy Treasury Futures This Tuesday, 35 Years of Trading Data Show

Holidays offer a predictable break in the calendar, and a reliable way to cash in on the Treasury market, according to Morgan Stanley.

Prices of 10-year Treasury futures move differently around every holiday, but they’re consistent enough on an annual basis to successfully trade on, strategists Tony Small and Matthew Hornbach found.

By studying patterns around 10 U.S. holidays as far back as 1983 when Treasury trading is either closed or minimal, the analysts came up with strategies for each event. When executed together each year, the trades would have been profitable annually since 1987.

It just so happens that the U.S. Memorial Day holiday on Monday, May 28, when U.S. financial markets will be shut, provides the next opportunity.

The strategists recommend buying 10-year futures on the Tuesday after the holiday and selling them on Friday. That approach returned 0.43 percent on average since 1983 and posted the best ratio of returns above benchmark, taking volatility into account, out of any the report tested. As it turns out, the trade works best when Memorial Day falls on May 28 or later.

“It’s possible that month-end rebalance flow or reinvestment of large quarterly refunding coupons occurs after the holiday and during this period,” the two strategists wrote in a Tuesday note.

July 4 Window

Looking ahead to the U.S. summer, the analysts recommend buying futures two days after the U.S. Independence Day holiday in July, and selling them two trading days later, as “summer seasonality, possible flows associated with the start of a new quarter, and flows observed from Japanese insurance buying may be at work.”

The overall strategy returned an average of 2.22 percent since inception. It had its best year in 2008, returning 7.33 percent. Its worst performance was a loss of 2.54 percent in 1987. All trades were made either at 3 p.m. in New York or at the time prices are settled if the market closes early for a holiday.

“While history seldom repeats itself, it may rhyme enough for this strategy to offer investors an idea about how to tactically trade around U.S. holidays,” the analysts wrote.

LISTEN TO ARTICLE 2:09 Share Share on Facebook Post to Twitter Send as an Email Print

Insider Buying: Groundstar Res (GSA) Director Acquires 685,000 Shares of Stock

Groundstar Res (CVE:GSA) Director Donald Gordon purchased 685,000 shares of the stock in a transaction that occurred on Tuesday, May 15th. The shares were acquired at an average cost of C$0.02 per share, with a total value of C$13,700.00.

Donald Gordon also recently made the following trade(s):

Get Groundstar Res alerts: On Friday, April 6th, Donald Gordon purchased 80,000 shares of Groundstar Res stock. The shares were acquired at an average cost of C$0.02 per share, with a total value of C$1,600.00.

Shares of CVE GSA opened at C$0.02 on Wednesday. Groundstar Res has a 1 year low of C$0.01 and a 1 year high of C$0.02.

Groundstar Res Company Profile

Groundstar Resources Limited explores for, develops, and produces oil and gas properties in Canada. The company was formerly known as Gramara Mercantile Corporation Ltd. and changed its name to Groundstar Resources Limited in July 1973. Groundstar Resources Limited was incorporated in 1968 and is headquartered in Calgary, Canada.

LaSalle Hotel Properties Shares Jump on $4.8B Blackstone Buyout

LaSalle Hotel Properties (NYSE:LHO) shares were soaring Monday as the company has agreed to be acquired by private equity firm Blackstone Group LP (NYSE:BX).

The merger will cost the New York investment group about $4.8 billion, giving it a larger share of the hotel market as the Bethesda-based company owns dozens of upscale hotels. The deal tops Pebblebrook Hotel Trust’s (NYSE:PEB) attempt at buying LaSalle Hotel Properties as the real estate investment trust attempted to buy the company for $3.7 billion.

The announcement arrived only three days after Blackstone had said that it would sell the last of its Hilton Worldwide Holdings shares, which are worth about $1.3 billion. Blackstone has been a Hilton investor for 11 years. This move is considered to be the most successful private equity deal on record, according to a Bloomberg News report.

“We are pleased to have reached this agreement with Blackstone, which we believe is in the best interests of our shareholders and represents the culmination of a thorough review of strategic alternatives,” said Stuart L. Scott, Chairman of the Board of LaSalle.

LaSalle’s board and its advisers said it had contacted 20 potential buyers. The Blackstone deal is slated to close in the third quarter, although it would still need to be approved by LaSalle shareholders.

LHO stock surged 5.6%  Monday, while BX stock gained 1.8%.

Compare Brokers

Quanterix Corp. (QTRX) Expected to Post Earnings of -$0.28 Per Share

Analysts expect that Quanterix Corp. (NASDAQ:QTRX) will announce ($0.28) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Quanterix’s earnings, with the lowest EPS estimate coming in at ($0.33) and the highest estimate coming in at ($0.23). The company is scheduled to report its next earnings report after the market closes on Wednesday, May 9th.

On average, analysts expect that Quanterix will report full year earnings of ($1.12) per share for the current financial year, with EPS estimates ranging from ($1.17) to ($1.06). For the next financial year, analysts anticipate that the company will post earnings of ($0.56) per share, with EPS estimates ranging from ($0.69) to ($0.42). Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Quanterix.

Get Quanterix alerts:

Quanterix (NASDAQ:QTRX) last announced its quarterly earnings data on Wednesday, May 9th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.25) by ($0.08).

Several equities research analysts have weighed in on the stock. BTIG Research reissued a “buy” rating and set a $26.00 price target on shares of Quanterix in a research report on Sunday, May 13th. ValuEngine raised shares of Quanterix from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. Finally, Zacks Investment Research cut shares of Quanterix from a “hold” rating to a “sell” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $26.50.

Shares of Quanterix traded up $0.43, reaching $20.08, during trading on Friday, MarketBeat.com reports. The company’s stock had a trading volume of 67,100 shares, compared to its average volume of 109,252. Quanterix has a 52-week low of $15.30 and a 52-week high of $24.81. The stock has a market capitalization of $421.20 million and a price-to-earnings ratio of -2.42.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. California State Teachers Retirement System purchased a new stake in Quanterix during the 1st quarter valued at $129,000. Opaleye Management Inc. boosted its position in Quanterix by 130.8% during the 1st quarter. Opaleye Management Inc. now owns 150,000 shares of the company’s stock valued at $2,556,000 after buying an additional 85,000 shares during the period. Citadel Advisors LLC purchased a new stake in Quanterix during the 1st quarter valued at $431,000. BlackRock Inc. purchased a new stake in Quanterix during the 1st quarter valued at $3,439,000. Finally, Northern Trust Corp purchased a new stake in Quanterix during the 1st quarter valued at $894,000. 45.89% of the stock is owned by institutional investors and hedge funds.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and Quanterix SR-X, which utilizes the same technology and assay kit as the Simoa HD-1 Analyzer.

Get a free copy of the Zacks research report on Quanterix (QTRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com